{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:13:51Z","timestamp":1776269631168,"version":"3.50.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>The role of enriched autologous plasmas in androgenetic alopecia (AGA) management is emerging in recent literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>In this prospective study, the authors aimed to confirm that the induction of a minor local trauma immediately followed by injections of an enriched plasma made of a strongly concentrated platelet fraction, a robust white cell presence, concentrated fibrinogen, and other plasma proteins (injectable leukocyte platelet-rich fibrin [iL-PRF]) could be able to produce positive clinical results in patients with AGA.<\/jats:p><\/jats:sec><jats:sec><jats:title>MATERIALS AND METHODS<\/jats:title><jats:p>A 2-injection regimen was instituted, with a 3-month interval between the 2 interventions. A treatment group (TG) and a control group (CG) were instituted. Macrophotographs were taken at baseline and after 6 months, and rated by 5-people expert panel (blinded to this assignment) using the 15-point scale proposed by Jaeschke to evaluate the clinical change.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Overall, TG showed better scores compared with the CG in all 5 classes of global physician assessment at baseline, all age groups, and in both sexes, and such differences always reached statistical significance. A greater severity at baseline showed a larger improvement after treatment in the TG.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>This study provides preliminary evidence that the biological composition of the iL-PRF is of crucial importance in ensuring a good degree of clinical efficacy in patients with AGA.<\/jats:p><\/jats:sec>","DOI":"10.1097\/dss.0000000000001584","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T12:37:13Z","timestamp":1532003833000},"page":"1183-1190","source":"Crossref","is-referenced-by-count":28,"title":["Injectable Platelet-, Leukocyte-, and Fibrin-Rich Plasma (iL-PRF) in the Management of Androgenetic Alopecia"],"prefix":"10.1097","volume":"44","author":[{"given":"Giovanni","family":"Schiavone","sequence":"first","affiliation":[{"name":"Plastic Surgery and Regenerative Surgery Unit, IDI-IRCCS, FLMM, Rome, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Paradisi","sequence":"additional","affiliation":[{"name":"Dermatology Unit, \u201cCristo Re\u201d General Hospital, Rome, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Ricci","sequence":"additional","affiliation":[{"name":"Dermatological Day Surgery Unit, IDI-IRCCS, FLMM, Rome, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damiano","family":"Abeni","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Unit, IDI-IRCCS, FLMM, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/01.DSS.0000452630.76339.fd","article-title":"Commentary on platelet-rich plasma for androgenetic alopecia: a pilot study","volume":"40","author":"Singh","year":"2014","journal-title":"Dermatol Surg"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/0974-2077.138353","article-title":"Platelet rich plasma in androgenic alopecia: where do we stand?","volume":"7","author":"Godse","year":"2014","journal-title":"J Cutan Aesthet Surg"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0974-2077.138352","article-title":"Platelet-rich plasma in androgenic alopecia: myth or an effective tool","volume":"7","author":"Khatu","year":"2014","journal-title":"J Cutan Aesthet Surg"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/01.DSS.0000452629.76339.2b","article-title":"Platelet-rich plasma for androgenetic alopecia: a pilot study","volume":"40","author":"Schiavone","year":"2014","journal-title":"Dermatol Surg"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/0974-7753.111222","article-title":"Role of platelet-rich plasma in the management of androgenetic alopecia","volume":"4","author":"Chaudhari","year":"2012","journal-title":"Int J Trichology"},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40257-016-0196-2","article-title":"Autologous platelet-rich plasma for the treatment of pattern hair loss","volume":"17","author":"Singh","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/DSS.0000000000000665","article-title":"Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia","volume":"42","author":"Alves","year":"2016","journal-title":"Dermatol Surg"},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/0974-2077.150743","article-title":"Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an 1-year period","volume":"7","author":"Gkini","year":"2014","journal-title":"J Cutan Aesthet Surg"},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-0034-1371896","article-title":"Platelet-rich fibrin matrix (PRFM) for androgenetic alopecia","volume":"30","author":"Sclafani","year":"2014","journal-title":"Facial Plast Surg"},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/DSS.0000000000000901","article-title":"A mechanistic model of platelet-rich plasma treatment for androgenetic alopecia","volume":"42","author":"Gupta","year":"2016","journal-title":"Dermatol Surg"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1423-0410.2009.01188.x","article-title":"Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure","volume":"97","author":"Mazzucco","year":"2009","journal-title":"Vox Sang"},{"key":"R12-20230814","first-page":"1","article-title":"Platelet rich plasma for treatment of non-scarring hair loss: systematic review of literature","volume":"23","author":"Ayatollahi","year":"2017","journal-title":"J Dermatol Treat"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/jocd.12331","article-title":"Platelet-rich plasma for androgenetic alopecia: does it work? Evidence from meta analysis","volume":"16","author":"Giordano","year":"2017","journal-title":"J Cosmet Dermatol"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jormas.2017.06.011","article-title":"Injections of platelet-rich plasma for androgenic alopecia: a systematic review","volume":"118","author":"Picard","year":"2017","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/0974-7753.160098","article-title":"Platelet-rich plasma as a potential treatment for noncicatricial alopecias","volume":"7","author":"Maria-Angeliki","year":"2015","journal-title":"Int J Trichology"},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/DSS.0000000000000883","article-title":"Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia","volume":"42","author":"Puig","year":"2016","journal-title":"Dermatol Surg"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","article-title":"Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)","volume":"27","author":"Dohan Ehrenfest","year":"2009","journal-title":"Trends Biotechnol"},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.blre.2013.02.001","article-title":"Blood-derived biomaterials and platelet growth factors in regenerative medicine","volume":"27","author":"Burnouf","year":"2013","journal-title":"Blood Rev"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2174\/138920112800624292","article-title":"Platelet-rich plasma (PRP) and Platelet-Rich Fibrin (PRF): surgical adjuvants, preparations for in situ regenerative medicine and tools for tissue engineering","volume":"13","author":"Bielecki","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.tripleo.2005.07.010","article-title":"Platelet-rich fibrin (PRF): a second-generation platelet concentrate: leucocyte activation: a new feature for platelet concentrates?","volume":"101","author":"Dohan Ehrenfest","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.tripleo.2005.07.009","article-title":"Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features","volume":"101","author":"Dohan","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1440-0960.2002.t01-1-00631.x","article-title":"Methods of evaluating hair growth","volume":"44","author":"Chamberlain","year":"2003","journal-title":"Australas J Dermatol"},{"key":"R23-20230814","first-page":"401","article-title":"Effect of membrane dimensions and shear rate on plasma filtration for hollow fibers","volume":"30","author":"Jaffrin","year":"1984","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1378\/chest.124.3_suppl.18S","article-title":"Thrombin and platelet activation","volume":"124","author":"Brass","year":"2003","journal-title":"Chest"},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1468-3083.2006.01568.x","article-title":"Critical study of hair growth analysis with computer-assisted methods","volume":"20","author":"Van Neste","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/0974-7753.66905","article-title":"Automated digital image analysis (TrichoScan) for human hair growth analysis: ease versus errors","volume":"2","author":"Saraogi","year":"2010","journal-title":"Int J Trichology"},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0974-7753.82118","article-title":"Clinical photography for trichology practice: tips and tricks","volume":"3","author":"Ashique","year":"2011","journal-title":"Int J Trichology"},{"key":"R29-20230814","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1537-2995.1991.31892023501.x","article-title":"Reducing white cells in platelet units","volume":"31","author":"Marx","year":"1991","journal-title":"Transfusion"},{"key":"R30-20230814","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrm3176","article-title":"Molecular control of endothelial cell behavior during blood vessel morphogenesis","volume":"12","author":"Herbert","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1634\/stemcells.2007-0054","article-title":"The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities","volume":"25","author":"Ponte","year":"2007","journal-title":"Stem Cells"},{"key":"R32-20230814","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1523-1747.2000.00954.x","article-title":"Active hair growth (anagen) is associated with angiogenesis","volume":"114","author":"Mecklenburg","year":"2000","journal-title":"J Invest Dermatol"},{"key":"R33-20230814","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/jdv.12062","article-title":"The effect of CD34+ cell-containing autologous platelet-rich plasma injection on pattern hair loss: a preliminary study","volume":"28","author":"Kang","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R34-20230814","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/j.1524-4725.2011.02123.x","article-title":"Enhanced effect of platelet-rich plasma containing a new carrier on hair growth","volume":"37","author":"Takikawa","year":"2011","journal-title":"Dermatol Surg"},{"key":"R35-20230814","first-page":"161","article-title":"The role of growth factors, cytokines and proteases in wound management","volume":"9","author":"Traversa","year":"2001","journal-title":"AWMA J"},{"key":"R36-20230814","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/wound.2014.0603","article-title":"Extracellular matrix-inspired growth factor delivery systems for skin wound healing","volume":"4","author":"Briquez","year":"2015","journal-title":"Adv Wound Care"},{"key":"R37-20230814","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.1247663","article-title":"Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing","volume":"343","author":"Mika\u00ebl","year":"2014","journal-title":"Science"},{"key":"R38-20230814","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s00784-016-1719-1","article-title":"Comparative release of growth factors from PRP, PRF, and advanced-PRF","volume":"20","author":"Kobayashi","year":"2016","journal-title":"Clin Oral Investig"},{"key":"R39-20230814","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/adhm.201200197","article-title":"Engineering the regenerative microenvironment with biomaterials","volume":"2","author":"Rice","year":"2013","journal-title":"Adv Healthc Mater"},{"key":"R40-20230814","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nbt1055","article-title":"Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering","volume":"23","author":"Lutolf","year":"2005","journal-title":"Nat Biotechnol"},{"key":"R41-20230814","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/art.38576","article-title":"Identification of alpha 2 macroglobulin as a master inhibitor of cartilage degrading factors that attenuates post-traumatic osteoarthritis progression","volume":"66","author":"Wang","year":"2014","journal-title":"Arthritis Reumatol"},{"key":"R42-20230814","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/jcp.24266","article-title":"Alpha-2-Macroglobulin: a physiological guardian","volume":"228","author":"Rehman","year":"2013","journal-title":"J Cell Physiol"},{"key":"R43-20230814","first-page":"3","article-title":"Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins","volume":"65","author":"LaMarre","year":"1991","journal-title":"Lab Invest"},{"key":"R44-20230814","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1096\/fasebj.6.15.1281457","article-title":"Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics","volume":"6","author":"Borth","year":"1992","journal-title":"FASEB J"},{"key":"R45-20230814","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1242\/jcs.00059","article-title":"Fibronectin at a glance","volume":"115","author":"Pankov","year":"2002","journal-title":"J Cell Sci"},{"key":"R46-20230814","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2174\/138920112800624382","article-title":"Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF)","volume":"13","author":"Dohan Ehrenfest","year":"2012","journal-title":"Curr Pharm Biotechnol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042728-201809000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T11:35:24Z","timestamp":1720438524000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201809000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000001584","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}